Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.

Wang H, Jain S, Li P, Lin JX, Oh J, Qi C, Gao Y, Sun J, Sakai T, Naghashfar Z, Abbasi S, Kovalchuk AL, Bolland S, Nutt SL, Leonard WJ, Morse HC 3rd.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9511-9520. doi: 10.1073/pnas.1901258116. Epub 2019 Apr 18.

PMID:
31000603
2.

Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Ledov VA, Golovina ME, Markina AA, Knirel YA, L'vov VL, Kovalchuk AL, Aparin PG.

Vaccine. 2019 Feb 14;37(8):1062-1072. doi: 10.1016/j.vaccine.2018.12.067. Epub 2019 Jan 19.

3.

3'Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations.

Kovalchuk AL, Sakai T, Qi CF, Du Bois W, Dunnick WA, Cogné M, Morse HC 3rd.

Oncotarget. 2018 Oct 2;9(77):34528-34542. doi: 10.18632/oncotarget.26160. eCollection 2018 Oct 2.

4.

The Energetics and Physiological Impact of Cohesin Extrusion.

Vian L, Pękowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N, Sanborn AL, Canela A, Maman Y, Oksanen A, Resch W, Li X, Lee B, Kovalchuk AL, Tang Z, Nelson S, Di Pierro M, Cheng RR, Machol I, St Hilaire BG, Durand NC, Shamim MS, Stamenova EK, Onuchic JN, Ruan Y, Nussenzweig A, Levens D, Aiden EL, Casellas R.

Cell. 2018 Sep 20;175(1):292-294. doi: 10.1016/j.cell.2018.09.002. No abstract available.

5.

Transcriptional activation of p21Waf1 contributes to suppression of HR by p53 in response to replication arrest induced by camptothecin.

Romanova LY, Mushinski F, Kovalchuk AL.

Oncotarget. 2018 May 22;9(39):25427-25440. doi: 10.18632/oncotarget.25172. eCollection 2018 May 22.

6.

The Energetics and Physiological Impact of Cohesin Extrusion.

Vian L, Pękowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N, Sanborn AL, Canela A, Maman Y, Oksanen A, Resch W, Li X, Lee B, Kovalchuk AL, Tang Z, Nelson S, Di Pierro M, Cheng RR, Machol I, St Hilaire BG, Durand NC, Shamim MS, Stamenova EK, Onuchic JN, Ruan Y, Nussenzweig A, Levens D, Aiden EL, Casellas R.

Cell. 2018 May 17;173(5):1165-1178.e20. doi: 10.1016/j.cell.2018.03.072. Epub 2018 Apr 26. Erratum in: Cell. 2018 Sep 20;175(1):292-294.

7.

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells.

Wang H, Gonzalez-Garcia I, Traba J, Jain S, Conteh S, Shin DM, Qi C, Gao Y, Sun J, Kang S, Abbasi S, Naghashfar Z, Yoon J, DuBois W, Kovalchuk AL, Sack MN, Duffy P, Morse HC 3rd.

Sci Rep. 2017 Dec 19;7(1):17867. doi: 10.1038/s41598-017-18028-z.

8.

Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Jain S, Ward JM, Shin DM, Wang H, Naghashfar Z, Kovalchuk AL, Morse HC 3rd.

Am J Pathol. 2017 Sep;187(9):2020-2033. doi: 10.1016/j.ajpath.2017.05.017. Epub 2017 Jul 17.

9.

DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.

Sakai T, Miyazaki T, Shin DM, Kim YS, Qi CF, Fariss R, Munasinghe J, Wang H, Kovalchuk AL, Kothari PH, Fermaintt CS, Atkinson JP, Perrino FW, Yan N, Morse HC 3rd.

J Autoimmun. 2017 Jul;81:13-23. doi: 10.1016/j.jaut.2017.03.001. Epub 2017 Mar 18.

10.

EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.

Niss Arfelt K, Barington L, Benned-Jensen T, Kubale V, Kovalchuk AL, Daugvilaite V, Christensen JP, Thomsen AR, Egerod KL, Bassi MR, Spiess K, Schwartz TW, Wang H, Morse HC 3rd, Holst PJ, Rosenkilde MM.

Blood. 2017 Feb 16;129(7):866-878. doi: 10.1182/blood-2016-02-697185. Epub 2016 Dec 21.

11.

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.

Tompkins VS, Sompallae R, Rosean TR, Walsh S, Acevedo M, Kovalchuk AL, Han SS, Jing X, Holman C, Rehg JE, Herms S, Sunderland JS, Morse HC, Janz S.

Blood Cancer J. 2016 Nov 4;6(11):e488. doi: 10.1038/bcj.2016.95.

12.

IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma.

Jain S, Chen J, Nicolae A, Wang H, Shin DM, Adkins EB, Sproule TJ, Leeth CM, Sakai T, Kovalchuk AL, Raffeld M, Ward JM, Rehg JE, Waldmann TA, Jaffe ES, Roopenian DC, Morse HC 3rd.

Am J Pathol. 2015 Nov;185(11):3102-14. doi: 10.1016/j.ajpath.2015.07.021. Epub 2015 Sep 9.

13.

Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation.

Kieffer-Kwon KR, Tang Z, Mathe E, Qian J, Sung MH, Li G, Resch W, Baek S, Pruett N, Grøntved L, Vian L, Nelson S, Zare H, Hakim O, Reyon D, Yamane A, Nakahashi H, Kovalchuk AL, Zou J, Joung JK, Sartorelli V, Wei CL, Ruan X, Hager GL, Ruan Y, Casellas R.

Cell. 2013 Dec 19;155(7):1507-20. doi: 10.1016/j.cell.2013.11.039.

14.

Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC.

Qi CF, Zhang R, Sun J, Li Z, Shin DM, Wang H, Kovalchuk AL, Sakai T, Xiong H, Kon N, Gu W, Morse HC 3rd.

Leuk Res. 2013 Dec;37(12):1680-9. doi: 10.1016/j.leukres.2013.09.009. Epub 2013 Sep 20.

15.

Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions.

Wang H, Shin DM, Abbasi S, Jain S, Kovalchuk AL, Beaty N, Chen S, Gonzalez-Garcia I, Morse HC 3rd.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20077-82. doi: 10.1073/pnas.1212428109. Epub 2012 Nov 19.

16.

Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus.

Spehalski E, Kovalchuk AL, Collins JT, Liang G, Dubois W, Morse HC 3rd, Ferguson DO, Casellas R, Dunnick WA.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13728-32. doi: 10.1073/pnas.1202882109. Epub 2012 Aug 6.

17.

Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.

Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse HC 3rd.

Int J Mol Sci. 2012;13(5):6204-19. doi: 10.3390/ijms13056204. Epub 2012 May 21.

18.

Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC 3rd, Potter M, Nussenzweig MC, Casellas R.

Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10972-7. doi: 10.1073/pnas.1200106109. Epub 2012 Jun 18.

19.

Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK/STAT and AKT signaling in mouse plasmacytomas.

Li Z, Qi CF, Shin DM, Zingone A, Newbery HJ, Kovalchuk AL, Abbott CM, Morse HC 3rd.

PLoS One. 2010 May 21;5(5):e10755. doi: 10.1371/journal.pone.0010755.

20.

Phosphorylation of paxillin at threonine 538 by PKCdelta regulates LFA1-mediated adhesion of lymphoid cells.

Romanova LY, Holmes G, Bahte SK, Kovalchuk AL, Nelson PJ, Ward Y, Gueler F, Mushinski JF.

J Cell Sci. 2010 May 1;123(Pt 9):1567-77. doi: 10.1242/jcs.060996. Epub 2010 Apr 13.

21.

Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.

Qi CF, Shin DM, Li Z, Wang H, Feng J, Hartley JW, Fredrickson TN, Kovalchuk AL, Morse HC 3rd.

J Pathol. 2010 May;221(1):106-16. doi: 10.1002/path.2692.

22.

Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.

Casellas R, Yamane A, Kovalchuk AL, Potter M.

Immunology. 2009 Mar;126(3):316-28. doi: 10.1111/j.1365-2567.2008.03050.x. Review.

23.

Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments.

Qi CF, Li Z, Raffeld M, Wang H, Kovalchuk AL, Morse HC 3rd.

Immunol Res. 2009;45(1):62-74. doi: 10.1007/s12026-008-8032-2.

24.

AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.

Kovalchuk AL, duBois W, Mushinski E, McNeil NE, Hirt C, Qi CF, Li Z, Janz S, Honjo T, Muramatsu M, Ried T, Behrens T, Potter M.

J Exp Med. 2007 Nov 26;204(12):2989-3001. Epub 2007 Nov 6.

25.

Differential cutaneous wound healing in thermally injured MRL/MPJ mice.

Davis TA, Amare M, Naik S, Kovalchuk AL, Tadaki D.

Wound Repair Regen. 2007 Jul-Aug;15(4):577-88.

PMID:
17650103
26.

Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.

Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC 3rd.

Cancer Res. 2007 Mar 15;67(6):2439-47.

27.
28.

E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.

Kovalchuk AL, Kim JS, Janz S.

Oncogene. 2003 May 8;22(18):2842-50.

PMID:
12743607
29.

Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations.

Rockwood LD, Torrey TA, Kim JS, Coleman AE, Kovalchuk AL, Xiang S, Ried T, Morse HC 3rd, Janz S.

Oncogene. 2002 Oct 17;21(47):7235-40.

31.

IL-6 transgenic mouse model for extraosseous plasmacytoma.

Kovalchuk AL, Kim JS, Park SS, Coleman AE, Ward JM, Morse HC 3rd, Kishimoto T, Potter M, Janz S.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1509-14. Epub 2002 Jan 22.

32.

Non-Hodgkin lymphomas of mice.

Hori M, Xiang S, Qi CF, Chattopadhyay SK, Fredrickson TN, Hartley JW, Kovalchuk AL, Bornkamm GW, Janz S, Copeland NG, Jenkins NA, Ward JM, Morse HC 3rd.

Blood Cells Mol Dis. 2001 Jan-Feb;27(1):217-22.

PMID:
11358382
33.

Translocation remodeling in the primary BALB/c plasmacytoma TEPC 3610.

Kovalchuk AL, Esa A, Coleman AE, Park SS, Ried T, Cremer CC, Janz S.

Genes Chromosomes Cancer. 2001 Mar;30(3):283-91.

PMID:
11170286
34.

Inducible mutagenesis in TEPC 2372, a mouse plasmacytoma cell line that harbors the transgenic shuttle vector lambdaLIZ.

Felix K, Kovalchuk AL, Park SS, Coleman AE, Ramsay ES, Qian M, Kelliher KA, Jones GM, Ried T, Bornkamm GW, Janz S.

Mutat Res. 2001 Jan 25;473(1):121-36.

PMID:
11166031
35.

Burkitt lymphoma in the mouse.

Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC 3rd.

J Exp Med. 2000 Oct 16;192(8):1183-90.

37.

Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations.

Kovalchuk AL, Mushinski EB, Janz S.

Leukemia. 2000 May;14(5):909-21.

PMID:
10803525
38.

Cytogenetic analysis of the bipotential murine pre-B cell lymphoma, P388, and its derivative macrophage-like tumor, P388D1, using SKY and CGH.

Coleman AE, Forest ST, McNeil N, Kovalchuk AL, Ried T, Janz S.

Leukemia. 1999 Oct;13(10):1592-600.

PMID:
10516761
39.

Jumping translocation breakpoint regions lead to amplification of rearranged Myc.

Coleman AE, Kovalchuk AL, Janz S, Palini A, Ried T.

Blood. 1999 Jun 15;93(12):4442-4. No abstract available.

40.

Deletional remodeling of c-myc-deregulating chromosomal translocations.

Kovalchuk AL, Müller JR, Janz S.

Oncogene. 1997 Nov 6;15(19):2369-77.

41.

Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.

Janz S, Kovalchuk AL, Müller JR, Potter M.

Curr Top Microbiol Immunol. 1997;224:241-50.

PMID:
9308247
42.

DNA sequence analysis of the genetic recombination between Igh6 and Myc in an uncommon BALB/c plasmacytoma, TEPC 1194.

Kovalchuk AL, Potter M, Janz S.

Immunogenetics. 1996;44(2):151-6. No abstract available.

PMID:
8662079

Supplemental Content

Loading ...
Support Center